Gabi 期刊-仿制药和生物仿制药倡议期刊 SCIE

期刊简介预计审稿时间：

The GaBI Journal Generics and Biosimilars Initiative Journal (GABI J) is an academic journal dedicated to the field of generic drugs and biosimilars. This journal is committed to promoting the research, development, and application of generic drugs and biosimilars, providing an important communication platform for academia and industry.

GABI J is published or managed by Pro Pharma Communications International and is located in Belgium. This journal has been included in authoritative databases such as Emerging Sources Citation Index (ESCI), demonstrating its significant influence in the fields of generic drugs and biosimilars. At the same time, GABI J also provides paper editing, translation, typesetting and other services through platforms such as LetPub, helping global authors publish high-quality research papers smoothly.

《Gabi 期刊-仿制药和生物仿制药倡议期刊》（简称GABI J）是一本专注于仿制药（Generics）和生物类似药（Biosimilars）领域的学术期刊。该期刊致力于推动仿制药和生物类似药的研究、开发与应用，为学术界和产业界提供了一个重要的交流平台。

GABI J由Pro Pharma Communications International出版或管理，出版地位于比利时（Belgium）。该期刊被Emerging Sources Citation Index (ESCI)等权威数据库收录，显示出其在仿制药和生物类似药领域的一定影响力。同时，GABI J还通过LetPub等平台提供论文编辑、翻译、排版等服务，助力全球作者顺利发表高质量的研究论文。

如果您需要协助投稿或润稿服务，您可以咨询我们的客服老师。我们专注于期刊投稿服务十年，熟悉发表政策，可为您提供一对一投稿指导，避免您在投稿时频繁碰壁，节省您的宝贵时间，有效提升发表机率，确保SCI检索（检索不了全额退款）。我们视信誉为生命，多方面确保文章安全保密，在任何情况下都不会泄露您的个人信息或稿件内容。